Tirofiban is superior to aspirin in non-obstructive strokes

Published Date: 08 Mar 2023

Results from the RESCUE BT2 trial showed that among patients with mild or major strokes, more patients taking tirofiban had better 90-day outcomes than aspirin.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Ineffective medication can remove the "worst fear" of schizophrenia.

2.

How access to specialized cancer centers affects glioblastoma outcomes

3.

Data indicate 1 in 3 US adults unaware of connection between HPV and cancers

4.

Since 2000, the outlook for multiple myeloma has improved.

5.

Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot